Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma
Open Access
- 1 January 2001
- Vol. 91 (1) , 155-163
- https://doi.org/10.1002/1097-0142(20010101)91:1<155::aid-cncr20>3.0.co;2-b
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Changing patterns of mortality across Europe in patients infected with HIV-1The Lancet, 1998
- Antiretroviral Therapy for HIV Infection in 1998JAMA, 1998
- Clinical Management of Human Immunodeficiency Virus-Associated Non-Hodgkin's LymphomaJNCI Monographs, 1998
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- AIDS oncologyCurrent Opinion in Infectious Diseases, 1998
- Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burdenInternational Journal of Cancer, 1997
- Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre studyBMJ, 1997
- Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centresAIDS, 1997
- Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapyThe American Journal of Medicine, 1993
- Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimenBlood, 1993